Latest period
$208B
YoY change
-2.5%
5Y CAGR
+6.2%
Peak year (FY2023)
$227B
Latest annual
$208B
Total Assets history chart for Pfizer (PFE) from 2016 to 2025
Latest: $208B
Total Assets growth chart for Pfizer (PFE) from 2016 to 2025
Latest: -2.5%
Total Assets history table for Pfizer (PFE) from 1985 to 2025
| FY2025 | $208B | -2.5% | -$5.24B | ||
| FY2024 | $213B | -5.8% | -$13.1B | ||
| FY2023 | $227B | +14.9% | +$29.3B | ||
| FY2022 | $197B | +8.7% | +$15.7B | ||
| FY2021 | $181B | +17.7% | +$27.2B | ||
| FY2020 | $154B | -7.9% | -$13.3B | ||
| FY2019 | $167B | +5.1% | +$8.07B | ||
| FY2018 | $159B | -7.2% | -$12.4B | ||
| FY2017 | $172B | +0.1% | +$182M | ||
| FY2016 | $172B | +2.5% | +$4.16B | ||
| FY2015 | $167B | -1.1% | -$1.81B | ||
| FY2014 | $169B | -1.6% | -$2.83B | ||
| FY2013 | $172B | -7.4% | -$13.7B | ||
| FY2012 | $186B | -1.2% | -$2.2B | ||
| FY2011 | $188B | -3.6% | -$7.01B | ||
| FY2010 | $195B | -8.4% | -$17.9B | ||
| FY2009 | $213B | +91.6% | +$102B | ||
| FY2008 | $111B | -3.6% | -$4.12B | ||
| FY2007 | $115B | +0.4% | +$431M | ||
| FY2006 | $115B | -2.3% | -$2.73B | ||
| FY2005 | $118B | -4.9% | -$6.12B | ||
| FY2004 | $124B | +5.9% | +$6.91B | ||
| FY2003 | $117B | +151.9% | +$70.4B | ||
| FY2002 | $46.4B | +18.4% | +$7.2B | ||
| FY2001 | $39.2B | +16.8% | +$5.64B | ||
| FY2000 | $33.5B | +62.9% | +$12.9B | ||
| FY1999 | $20.6B | +12.4% | +$2.27B | ||
| FY1998 | $18.3B | +19.3% | +$2.97B | ||
| FY1997 | $15.3B | +4.6% | +$669M | ||
| FY1996 | $14.7B | +15.2% | +$1.94B | ||
| FY1995 | $12.7B | +14.7% | +$1.63B | ||
| FY1994 | $11.1B | +18.9% | +$1.77B | ||
| FY1993 | $9.33B | -2.7% | -$259M | ||
| FY1992 | $9.59B | -0.5% | -$44.5M | ||
| FY1991 | $9.63B | +6.4% | +$583M | ||
| FY1990 | $9.05B | +8.7% | +$727M | ||
| FY1989 | $8.32B | +9.0% | +$687M | ||
| FY1988 | $7.64B | +10.3% | +$715M | ||
| FY1987 | $6.92B | +34.1% | +$1.76B | ||
| FY1986 | $5.16B | +15.7% | +$701M | ||
| FY1985 | $4.46B | — | — |
- FY2025$208B-2.5%
- FY2024$213B-5.8%
- FY2023$227B+14.9%
- FY2022$197B+8.7%
- FY2021$181B+17.7%
- FY2020$154B-7.9%
- FY2019$167B+5.1%
- FY2018$159B-7.2%
- FY2017$172B+0.1%
- FY2016$172B+2.5%
- FY2015$167B-1.1%
- FY2014$169B-1.6%
- FY2013$172B-7.4%
- FY2012$186B-1.2%
- FY2011$188B-3.6%
- FY2010$195B-8.4%
- FY2009$213B+91.6%
- FY2008$111B-3.6%
- FY2007$115B+0.4%
- FY2006$115B-2.3%
- FY2005$118B-4.9%
- FY2004$124B+5.9%
- FY2003$117B+151.9%
- FY2002$46.4B+18.4%
- FY2001$39.2B+16.8%
- FY2000$33.5B+62.9%
- FY1999$20.6B+12.4%
- FY1998$18.3B+19.3%
- FY1997$15.3B+4.6%
- FY1996$14.7B+15.2%
- FY1995$12.7B+14.7%
- FY1994$11.1B+18.9%
- FY1993$9.33B-2.7%
- FY1992$9.59B-0.5%
- FY1991$9.63B+6.4%
- FY1990$9.05B+8.7%
- FY1989$8.32B+9.0%
- FY1988$7.64B+10.3%
- FY1987$6.92B+34.1%
- FY1986$5.16B+15.7%
- FY1985$4.46B—
Total Assets values are taken from Pfizer's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Total Assets at Pfizer (PFE)
According to Pfizer's latest reported financial statements, the company's latest reported total assets is $208B. Total assets sum everything the company reports owning at the end of each reporting period — cash, receivables, inventory, property, plant, equipment, intangibles, and other holdings — as filed on the balance sheet. Compare with total liabilities and total equity for the capital-structure picture.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
As of the 2025 fiscal year, Pfizer (PFE) reported total assets of $208B – edged down 2.5% year-over-year.
Pfizer total assets has grown on net over the period, with a +6.2% compound annual growth rate over 2020–2025 (5 years).
Pfizer total assets peaked at $227B in 2023; the latest annual figure is $208B in 2025 (8.1% below peak).
The record annual total assets stands at $227B, reached in 2023; the historical low of $4.46B was recorded in 1985.
Pfizer Total Assets by Year
Pfizer Total Assets 2025: $208B
In 2025, Pfizer reported total assets of $208B, edged down 2.5% below 2024.
Pfizer Total Assets 2024: $213B
Pfizer total assets in 2024 was $213B, declined 5.8% below 2023.
Pfizer Total Assets 2023: $227B
2023's total assets for Pfizer came in at $227B, grew 14.9% from 2022. This figure represents the highest annual value in the available history.
Pfizer Total Assets 2022: $197B
Pfizer posted total assets of $197B in 2022, grew 8.7% from 2021.
Pfizer Total Assets 2021: $181B
Pfizer total assets in 2021 was $181B.
See more financial history for Pfizer (PFE).
Sector peers by Total Assets
Healthcare peers of Pfizer (PFE), ranked by their latest total assets
| $310B | |
| $199B | |
| $137B | |
| $134B | |
| $112B | |
| $110B | |
| $90.6B | |
| $85.4B |
- $137B
- $134B
- $112B
- $90.6B
- $85.4B
Frequently asked questions
Test yourself on PFE
Market Cap — 10 rounds, every one of them PFE against another company. Leave whenever you like.
Practice run — it doesn’t move your skill rating and doesn’t touch the leaderboards. Misses do go into your review queue.
Pfizer (PFE) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
- Buybacks
- Dividend Profile6.84% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History6 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.